Antengene Secures South Korean Approval for XPOVIO® in Combination Therapy for Multiple Myeloma

SHANGHAI and HONG KONG, Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmac...

October 18, 2024 | Friday | News
Amicus Therapeutics and Teva Pharmaceuticals Reach License Agreement on GALAFOLD®

Amicus Therapeutics (Nasdaq: FOLD) announced that it has entered into a License Agreement (Agreement) with Teva Pharmaceuticals USA, Inc. and Teva Pharmace...

October 18, 2024 | Friday | News
MSD's Clesrovimab Shows Promising Results in Protecting Infants from RSV in Phase 2b/3 Trial

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced the presentation of positive results from the Phase 2b/3 clinical trial ...

October 18, 2024 | Friday | News
Avirmax Biopharma to Showcase Innovative Gene Therapy Advances at AAO 2024

Avirmax Biopharma Inc. (ABI) team will attend AAO 2024, the American Academy of Ophthalmology's annual meeting in Chicago, October 17-21, 20...

October 16, 2024 | Wednesday | News
Sanofi Moves Toward Strategic Divestment, Negotiates 50% Stake Sale of Opella with CD&R

Sanofi  announces that the company has entered into negotiations with CD&R for the potential sale of a 50% controlling stake in Opella, its cons...

October 11, 2024 | Friday | News
Burning Rock and Dizal Announce First NGS-Based Lung Cancer Diagnostic Approval by China’s NMPA

Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), an innovative company in the field of precision onco...

October 11, 2024 | Friday | News
Basilea Pharmaceutica Secures $1.25 Million Milestone Payment Following Strong Sales of Cresemba® in Asia Pacific and China

Basilea Pharmaceutica Ltd, Allschwil , a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and ...

October 10, 2024 | Thursday | News
Amira Hovione and Zerion Pharma Expand Partnership to Accelerate Development of Dispersome® Technology

Hovione Farmaciência, S.A.(“HOVIONE”) and Zerion Pharma A/S (“ZERION”) today announced that they have expanded their part...

October 04, 2024 | Friday | News
MSD Acquires CN201 from Curon Biopharmaceutical, Advancing B-cell Disease Treatments

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced the completion of the acquisition of CN201 from Curon Biopharmaceutical ...

October 02, 2024 | Wednesday | News
Piramal Pharma Commits $80M to Transform Lexington Facility, Elevating Global Sterile Injectables Production

$80M investment plan will add commercial scale sterile injectables capabilities Expansion will significantly increase pr...

October 01, 2024 | Tuesday | News
Abzena's AbZelectPRO™ Platform Reduces Cell Line Development Timelines by 30%, Boosts Protein Production for Biopharma

Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, has announced that its mammalian cell line development platform, ...

September 27, 2024 | Friday | News
Agarose Bead Technologies Completes Major Expansion of Spanish Facility to Meet Global Demand for Pharmaceutical Resins

Agarose Bead Technologies (ABT), a leading manufacturer of high-quality agarose resins, proudly announces the completion of a major expansion at its faci...

September 25, 2024 | Wednesday | News
VERDOT® to Build New 4,200 Square-Meter Headquarters and Manufacturing Facility in Riom, France

4200 square-meter headquarter and manufacturing facility in Riom, France Consolidation of existing facilities with 150% additional manufacturing capacit...

September 23, 2024 | Monday | News
Australian Telix Pharmaceuticals to Acquire U.S. Radiopharmacy Network RLS in $230M Deal

Telix Pharmaceuticals Limited announced an agreement to acquire RLS (USA) Inc. (RLS), America's only Joint Commission-accredited radiopharmacy network sp...

September 23, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close